| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Oct―30 |
Avoidant/Restrictive Food Intake Disorder Inappetence Subtype, Precipitated by SARS-CoV-2 Olfactory and Gustatory Impairment, Treated Successfully With Methylphenidate |
David R. Spiegel, Melanie Gonzalez-Saavedra, Melissa Hoff, Jubilee Benedict |
| 2 |
[GO] |
2025―Sep―15 |
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms |
W. Michael Brode, Jacqueline Posada, Divya Nagireddy |
| 3 |
[GO] |
2025―Feb―08 |
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination |
Seshagiri Rao Doddi, Francis Pham, Jennifer Wineke, Christopher Marano, Deborah Brooks |
| 4 |
[GO] |
2025―Jan―22 |
COVID-19 and Neuroleptic Malignant Syndrome |
Greg Noe, Kaushal Shah, Samantha Ongchuan-Martin, Sahil Munjal |
| 5 |
[GO] |
2024―Apr―19 |
A Rapid Review of the Effects of the COVID-19 Vaccine Among Individuals Taking Clozapine |
Aparna Das, Amanda T. Sawyer, Prabhava Bagla |
| 6 |
[GO] |
2024―Feb―29 |
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19 |
Yen-An Koai, Chih-Chung Huang, Chih-Sung Liang, Ta-Chuan Yeh |
| 7 |
[GO] |
2023―Jun―24 |
Association Between Selective Serotonin Reuptake Inhibitors Prevalent Use and COVID-19-Related Mortality |
Pablo Ignacio Osores, María Noelia Vivacqua, Carolina Vazquez, Sebastián Marciano, Diego Hernán Giunta, José Luis Faccioli |
| 8 |
[GO] |
2023―Jun―14 |
Adherence to Psychotropic Medication Before and During COVID-19 |
Brandon Froese, Gian Aquino, Eunice Valencia, Qier Tan, Marina Yogendran, Cara Katz, et al. (+13) James M. Bolton, Jamie Falk, Kaarina Kowalec, Dan Chateau, Joseph C. Delaney, Sarvesh Logsetty, Rae Spiwak, Murray W. Enns, Jitender Sareen, Silvia Alessi-Severini, Kendiss Olafson, Sherif Eltonsy, Christine Leong |
| 9 |
[GO] |
2022―Dec―30 |
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India |
Avinash Shukla, Neethu K. Nandan, Lokesh Kumar Singh |
| 10 |
[GO] |
2022―Aug―02 |
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination |
Maximilian Hansbauer, Enikö Fastantz, Justina Lutz, Alkomiet Hasan |
| 11 |
[GO] |
2022―Apr―14 |
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review |
Udo Bonnet, Georg Juckel |
| 12 |
[GO] |
2022―Mar―09 |
A Decrease of Neutrophils After COVID-19 Vaccination in a Treatment-Resistant Patient With Schizophrenia Taking Clozapine |
Manabu Takaki, Yuji Yada, Shinji Sakamoto, Masaki Fujiwara, Yuko Okahisa, Norihito Yamada |
| 13 |
[GO] |
2022―Jan―29 |
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna) |
Christian Knöchel, Gudrun Hefner, Thomas Stiehl, Walter Schmidbauer |
| 14 |
[GO] |
2021―Oct―20 |
A Seizure After COVID-19 Vaccination in a Patient on Clozapine |
Ahmed T. Makhlouf, Manjola U. Van Alphen, Giovanna S. Manzano, Oliver Freudenreich |
| 15 |
[GO] |
2021―Apr―13 |
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic |
Júlia Cozar Pacheco, José Diogo S. Souza, Jaime E.C. Hallak, Flávia de Lima Osório, Alline C. Campos, Francisco S. Guimarães, et al. (+2) Antonio Waldo Zuardi, José Alexandre S. Crippa |
| 16 |
[GO] |
2021―Jan―14 |
Acetaminophen (Paracetamol), COVID-19, and Misleading Conclusions |
Richard I. Shader |
| 17 |
[GO] |
2020―Oct―31 |
Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines |
Ángel Ruiz de Pellón Santamaría |
